What the GLP-1 Benefits Beyond Weight Loss: Evidence Review GLP-1 agonists cut cardiovascular events, protect kidneys, and reverse liver disease
doi: 10.3389/fnut.2022.851275 Received 09 January 2022 Accepted 21 July 2022 Published 10 August 2022 Volume 9 - 2022 Edited by Alessandra Durazzo, Council for Agricultural Research and Economics, Italy Reviewed by Mohd Ashraf Ganie, Sher-I-Kashmir Institute of Medical Sciences, India
However, when food remains in the stomach longer, stomach acid has extended contact with the lower esophageal sphincter (LES), a muscle that normally prevents acid from backing up into the esophagus
As seen in Figure 1 and 2, there is a distribution of weight change after cessation of GLP1-RA therapy
Most published work is in rodent models
Individualized assessment matters